Early Rituximab Can Delay Need for Chemo in Follicular Lymphoma
(MedPage Today) — Long-term results from a randomized trial confirmed that early rituximab monotherapy for advanced-stage, asymptomatic, low tumor burden follicular lymphoma can substantially delay the need for further treatment.
At nearly 15…
